Predictive Oncology (POAI) Insider Trading & Ownership $1.00 +0.03 (+3.08%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$1.00 0.00 (-0.49%) As of 04/11/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Predictive Oncology (NASDAQ:POAI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.44%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$140,455.40Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$30,400.00 Get POAI Insider Trade Alerts Want to know when executives and insiders are buying or selling Predictive Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address POAI Insider Buying and Selling by Quarter Remove Ads Predictive Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/25/2023Charles Lee Sr Nuzum SrDirectorSell10,000$3.04$30,400.00 12/15/2022Daniel E HandleyDirectorBuy300$8.20$2,460.00 12/2/2022Raymond F VennareDirectorBuy250$10.40$2,600.00 12/2/2022Robert L MyersCFOBuy439$11.40$5,004.60 11/29/2022Daniel E HandleyDirectorBuy500$7.20$3,600.00 5/26/2022Daniel E HandleyDirectorBuy127$7.40$939.80 5/24/2022J Melville EngleDirectorBuy7,975$7.40$59,015.00 5/20/2022Charles Lee Sr Nuzum SrDirectorBuy10,000$6.20$62,000.00 5/20/2022Robert L MyersCFOBuy806$6.00$4,836.00 (Data available from 1/1/2013 forward) POAI Insider Trading Activity - Frequently Asked Questions Who is on Predictive Oncology's Insider Roster? The list of insiders at Predictive Oncology includes Charles Lee Sr Nuzum Sr, Daniel E Handley, J Melville Engle, Raymond F Vennare, and Robert L Myers. Learn more on insiders at POAI. What percentage of Predictive Oncology stock is owned by insiders? 3.44% of Predictive Oncology stock is owned by insiders. Learn more on POAI's insider holdings. Which Predictive Oncology insiders have been selling company stock? The following insider sold POAI shares in the last 24 months: Charles Lee Sr Nuzum Sr ($30,400.00). How much insider selling is happening at Predictive Oncology? Insiders have sold a total of 10,000 Predictive Oncology shares in the last 24 months for a total of $30,400.00 sold. Predictive Oncology Key ExecutivesMr. Raymond F. Vennare (Age 71)CEO & Chairman Compensation: $525kMr. Joshua Blacher M.B.A. (Age 51)Interim Chief Financial Officer Ms. Theresa FergusonSenior Director of MarketingDr. Lawrence J. DeLucas D.ScO.D, Ph.D., Senior Vice President of BiologicsDr. Arlette H. Uihlein FCAPM.D., Senior VP of Translational Medicine & Drug Discovery and Medical Director More Insider Trading Tools from MarketBeat Related Companies TELA Insider Ownership APYX Insider Ownership DXR Insider Ownership OM Insider Ownership MODD Insider Ownership POCI Insider Ownership MDAI Insider Ownership COCH Insider Ownership DRIO Insider Ownership NXL Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Joby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April? This page (NASDAQ:POAI) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
